NCT03450369View on ClinicalTrials.gov

A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 24, 2018

Primary Completion Date

June 18, 2018

Study Completion Date

June 18, 2018

Conditions
Acne Vulgaris
Interventions
BIOLOGICAL

NB01

Use an existing therapy designed to kill existing facial bacterial followed by populating facial skin with a single application of NB01

Trial Locations (1)

90045

Dermatology Research Associates, Los Angeles

Sponsors

Lead Sponsor

Naked Biome, Inc.
All Listed Sponsors
collaborator

Dermatology Research Institute

OTHER

collaborator

QST Consultations, Ltd.

INDUSTRY

collaborator

Science 37

INDUSTRY

lead

Naked Biome, Inc.

INDUSTRY